After ten years of market presence, serving early adopter and progressive veterinarians, we are ready to take our company to the next level
Poway, California (PRWEB) January 16, 2015
January 16th, 2015 – Leading Regenerative Veterinary Medicine company, Vet-Stem, Inc., CEO announced the hiring of President and Chief Commercial Officer, Alexis Nahama, DVM.
“After ten years of market presence, serving early adopter and progressive veterinarians, we are ready to take our company to the next level. We are heavy on science, and have engaged in the development of our next generation of therapeutic solutions, including working with the FDA towards obtaining approval for the first veterinary cellular therapy product to be used in helping dogs affected by osteoarthritis. In addition to its aim of reducing the pain of osteoarthritis, this therapy has the potential to impact the progression of the disease, and to promote tissue regeneration. Given the complexities of such developments, I have decided to focus most of my time to our research programs. I needed a great partner to take on the current operations and focus our commercial approach”, said Dr Bob Harman (CEO).
Dr. Harman and the board of directors announced the appointment of Dr. Alexis Nahama as the new Vet-Stem, Inc.’s President and Chief Commercial Officer.
Dr. Nahama, former head of marketing for VCA Inc. (Nasdaq: Woof), brings two decades of global veterinary industry experience with him, ranging from clinical development to managing some of the most influential brands in animal health.
“Our current technology has helped over 10,000 dogs, horses and cats through processing of their own fat tissue to extract stem cells that are then injected in painful joints, tendons or ligaments, but many owners are still unaware we have a possible solution for their animal’s need. Although not inexpensive, (great breakthrough technologies seldom are) this therapeutic approach is already available through many veterinarians today!” said Dr Nahama.
“Vet-Stem Inc., despite its’ relatively small size has the potential to dramatically change the way veterinarians address difficult diseases in the not so distant future. In a world of giant corporations, this company will be truly disruptive and benefit countless patients worldwide. It is with great pride and excitement that I take on these responsibilities and join this amazingly smart and dedicated group of people”,added Dr. Nahama.
“Alexis’ passion for helping pet owners and veterinarians, coupled with his extensive knowledge of the veterinary industry and his marketing expertise, is exactly what we need to succeed”, stated Dr. Harman. “I am happy to welcome him to be part of our leadership team.”
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held biotechnology enterprise, based near San Diego (California), currently offers veterinarians access to stem-cell therapy (extracted from the patients’ own fat tissue), among other regenerative treatment modalities. With over 10,000 patients treated by veterinarians for joint, tendons and ligament issues, Vet-Stem has made regenerative medicine applications a therapeutic reality beyond the realm of research. Development programs focused on products and services that utilize the natural tissue healing properties inherent in all living creatures, have the potential to dramatically improve the quality of life for our animals Vet-Stem’s progress in bringing practical and affordable medical solutions to market might change animal lives by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases.. Vet-Stem currently holds the exclusive licenses to over 55 patents including worldwide veterinary rights for use of adipose derived stem cells, with over 75 patents pending.
12860 Danielson Court, Suite B
Poway, CA 92064